Article: ORTEC SUCCESSFULY DEFENDS EUROPEAN PATENT ON ORCEL.

Ortec International (Nasdaq:ORTC), New York, has successfully defended an opposition filed with the European Patent Office by Advanced Tissue Sciences, Inc. challenging the validity of Ortec's European patent on OrCel(TM), Ortec's tissue engineering platform technology.

Commenting on the successful defense, Steven Katz, Ph.D., Ortec's chairman and CEO stated, "This is the second challenge from a competitor Ortec has successfully defended. We have always felt confident in the strength of our patent, and the European Patent Office's decision reaffirms the novelty and inventiveness of Ortec's leading technology." Advanced Tissue Sciences has the right to appeal for ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!